INM 8-K: Acquisition

InMed Pharmaceuticals completed its previously

Filed with the SEC on · accession 0001193125-26-462017

INM filed a 8-K (current report) with the SEC on Nov 16, 2026. InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three…

Summary of the filing

InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three and nine months ended September 30, 2026.

Key details

Pre-merger registrant, now renamed mentari therapeutics, inc.InMed Pharmaceuticals Inc.
Merger counterparty, now the combined public companyMentari Therapeutics, Inc. (private Delaware corporation)
Wholly owned merger subsidiary of inmedIndigo Merger Sub Corp.
Wholly owned merger subsidiary of inmedIndigo Merger Sub II, LLC
General counsel and corporate secretaryJerad G. Seurer

✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INM?

Click here

Frequently asked questions

What did INM file with the SEC on Nov 16, 2026?

INM filed a 8-K (Acquisition). InMed Pharmaceuticals completed its previously announced business combination with Mentari Therapeutics on November 6, 2026, and the combined company now operates as Mentari Therapeutics, Inc. This 8-K furnishes Mentari's unaudited condensed consolidated financial statements and MD&A for the three and nine months ended September 30, 2026.

What does a acquisition mean for INM stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other INM SEC filings

Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days